Selected research
Industry Growth & Trends
Global AI Clinical Trial Imaging Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Clinical Trial Imaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Clinical Trial Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Clinical Trial Imaging market include AICure, Brainomix, Clario, Lantern Pharma, Median, Neuroute, Owkin, PathAI and Quibim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Clinical Trial Imaging market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Clinical Trial Imaging market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Clinical Trial Imaging market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Clinical Trial Imaging.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Clinical Trial Imaging market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Clinical Trial Imaging Market by Company
AICure
Brainomix
Clario
Lantern Pharma
Median
Neuroute
Owkin
PathAI
Quibim
Saama
Spectral
VIDA
Voiant
AI Clinical Trial Imaging Segment by Type
Based on Machine Learning
Based on Deep Learning
Others
AI Clinical Trial Imaging Segment by Application
Telemedicine
Diagnostic Assistance
Clinical Decision Support
Others
AI Clinical Trial Imaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Trial Imaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Clinical Trial Imaging companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Based on Machine Learning
- Based on Deep Learning
- Others
Applications
- Telemedicine
- Diagnostic Assistance
- Clinical Decision Support
- Others
Companies covered
- AICure
- Brainomix
- Clario
- Lantern Pharma
- Median
- Neuroute
- Owkin
- PathAI
- Quibim
- Saama
- Spectral
- VIDA
- Voiant
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Clinical Trial Imaging Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Clinical Trial Imaging Market Size by Region (2021-2032)
- 1.4.1 Global AI Clinical Trial Imaging Market Size by Region (2021-2026)
- 1.4.2 Global AI Clinical Trial Imaging Market Size by Region (2027-2032)
- 1.5 Key Regions AI Clinical Trial Imaging Market Size (2021-2032)
- 1.5.1 North America AI Clinical Trial Imaging Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Clinical Trial Imaging Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Clinical Trial Imaging Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Clinical Trial Imaging Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Clinical Trial Imaging Market Size Growth Rate (2021-2032)
2 AI Clinical Trial Imaging Market by Type
- 2.1 Type Introduction
- 2.1.1 Based on Machine Learning
- 2.1.2 Based on Deep Learning
- 2.1.3 Others
- 2.2 Global AI Clinical Trial Imaging Market Size by Type
- 2.2.1 Global AI Clinical Trial Imaging Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Clinical Trial Imaging Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Clinical Trial Imaging Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Clinical Trial Imaging Market Size by Regions
- 2.3.1 North America AI Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Clinical Trial Imaging Market Size Breakdown by Type (2021-2026)
3 AI Clinical Trial Imaging Market by Application
- 3.1 Type Introduction
- 3.1.1 Telemedicine
- 3.1.2 Diagnostic Assistance
- 3.1.3 Clinical Decision Support
- 3.1.4 Others
- 3.2 Global AI Clinical Trial Imaging Market Size by Application
- 3.2.1 Global AI Clinical Trial Imaging Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Clinical Trial Imaging Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Clinical Trial Imaging Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Clinical Trial Imaging Market Size by Regions
- 3.3.1 North America AI Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Clinical Trial Imaging Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Clinical Trial Imaging Industry Trends
- 4.2 AI Clinical Trial Imaging Industry Drivers
- 4.3 AI Clinical Trial Imaging Industry Opportunities and Challenges
- 4.4 AI Clinical Trial Imaging Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Clinical Trial Imaging Revenue (2021-2026)
- 5.2 Global AI Clinical Trial Imaging Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Clinical Trial Imaging Key Company Headquarters & Area Served
- 5.4 Global AI Clinical Trial Imaging Company, Product Type & Application
- 5.5 Global AI Clinical Trial Imaging Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Clinical Trial Imaging Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Clinical Trial Imaging Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Clinical Trial Imaging Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AICure
- 6.1.1 AICure Company Information
- 6.1.2 AICure Business Overview
- 6.1.3 AICure AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AICure AI Clinical Trial Imaging Product Portfolio
- 6.1.5 AICure Recent Developments
- 6.2 Brainomix
- 6.2.1 Brainomix Company Information
- 6.2.2 Brainomix Business Overview
- 6.2.3 Brainomix AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Brainomix AI Clinical Trial Imaging Product Portfolio
- 6.2.5 Brainomix Recent Developments
- 6.3 Clario
- 6.3.1 Clario Company Information
- 6.3.2 Clario Business Overview
- 6.3.3 Clario AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Clario AI Clinical Trial Imaging Product Portfolio
- 6.3.5 Clario Recent Developments
- 6.4 Lantern Pharma
- 6.4.1 Lantern Pharma Company Information
- 6.4.2 Lantern Pharma Business Overview
- 6.4.3 Lantern Pharma AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Lantern Pharma AI Clinical Trial Imaging Product Portfolio
- 6.4.5 Lantern Pharma Recent Developments
- 6.5 Median
- 6.5.1 Median Company Information
- 6.5.2 Median Business Overview
- 6.5.3 Median AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Median AI Clinical Trial Imaging Product Portfolio
- 6.5.5 Median Recent Developments
- 6.6 Neuroute
- 6.6.1 Neuroute Company Information
- 6.6.2 Neuroute Business Overview
- 6.6.3 Neuroute AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Neuroute AI Clinical Trial Imaging Product Portfolio
- 6.6.5 Neuroute Recent Developments
- 6.7 Owkin
- 6.7.1 Owkin Company Information
- 6.7.2 Owkin Business Overview
- 6.7.3 Owkin AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Owkin AI Clinical Trial Imaging Product Portfolio
- 6.7.5 Owkin Recent Developments
- 6.8 PathAI
- 6.8.1 PathAI Company Information
- 6.8.2 PathAI Business Overview
- 6.8.3 PathAI AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 PathAI AI Clinical Trial Imaging Product Portfolio
- 6.8.5 PathAI Recent Developments
- 6.9 Quibim
- 6.9.1 Quibim Company Information
- 6.9.2 Quibim Business Overview
- 6.9.3 Quibim AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Quibim AI Clinical Trial Imaging Product Portfolio
- 6.9.5 Quibim Recent Developments
- 6.10 Saama
- 6.10.1 Saama Company Information
- 6.10.2 Saama Business Overview
- 6.10.3 Saama AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Saama AI Clinical Trial Imaging Product Portfolio
- 6.10.5 Saama Recent Developments
- 6.11 Spectral
- 6.11.1 Spectral Company Information
- 6.11.2 Spectral Business Overview
- 6.11.3 Spectral AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Spectral AI Clinical Trial Imaging Product Portfolio
- 6.11.5 Spectral Recent Developments
- 6.12 VIDA
- 6.12.1 VIDA Company Information
- 6.12.2 VIDA Business Overview
- 6.12.3 VIDA AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 VIDA AI Clinical Trial Imaging Product Portfolio
- 6.12.5 VIDA Recent Developments
- 6.13 Voiant
- 6.13.1 Voiant Company Information
- 6.13.2 Voiant Business Overview
- 6.13.3 Voiant AI Clinical Trial Imaging Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Voiant AI Clinical Trial Imaging Product Portfolio
- 6.13.5 Voiant Recent Developments
7 North America
- 7.1 North America AI Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 7.3 North America AI Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 8.3 Europe AI Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 10.3 South America AI Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Clinical Trial Imaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Clinical Trial Imaging Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Clinical Trial Imaging Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst